{"id":11084,"date":"2023-04-15T12:00:45","date_gmt":"2023-04-15T10:00:45","guid":{"rendered":"https:\/\/www.akern.com\/newsroom\/akern-consolida-i-rapporti-con-la-cina\/"},"modified":"2024-02-16T12:49:35","modified_gmt":"2024-02-16T11:49:35","slug":"akern-consolidates-relations-with-china","status":"publish","type":"post","link":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/","title":{"rendered":"Akern consolidates relations with China"},"content":{"rendered":"<p><strong>Akern<sup>\u00ae<\/sup>&#8216;s partnership with the Chinese company EnterNutr Guangzhou New Health Biotechnology Co., Ltd.,<\/strong> a Guangzhou-based company founded in 2008 by Dr. Hanxi Li, <strong>started in 2019<\/strong>. Today EnterNutr is a company supported by governmental funds and well-established in the hospital setting in providing supplements and devices for parenteral nutrition therapy.<\/p>\n<p>In 2022 Akern<sup>\u00ae<\/sup> obtained <strong>NMPA certification authorizing<\/strong> the <a href=\"https:\/\/www.akern.com\/en\/newsroom\/nutrilab-approved-for-use-in-the-peoples-republic-of-china\/\">sales<\/a> of its medical devices in the clinical market.<\/p>\n<p>This month Akern<sup>\u00ae<\/sup>&#8216;s CSO visited 8 well-known Chinese hospitals (including: 301 Concordia Hospital Beijing, Beijing National Hospital, Shenzhen Municipal Hospital, South Medical University Shenzhen Hospital, South Medical University Zhujiang Hospital) to initiate scientific collaborations and share ideas for research project in intensive care and oncology and geriatrics departments.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-11074\" src=\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-scaled.jpg\" alt=\"\" width=\"2560\" height=\"1157\" srcset=\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-scaled.jpg 2560w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-768x347.jpg 768w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-1536x694.jpg 1536w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-2048x926.jpg 2048w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-2-600x271.jpg 600w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-11077\" src=\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-3.jpg\" alt=\"\" width=\"2000\" height=\"1500\" srcset=\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-3.jpg 2000w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-3-768x576.jpg 768w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-3-1536x1152.jpg 1536w, https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina-3-600x450.jpg 600w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/p>\n<p><strong>2024 publications update:<\/strong><\/p>\n<ul>\n<li>Xie, Hailun, et al. &#8220;Association of systemic inflammation with the obesity paradox in cancer: results from multi-cohort studies.&#8221; <em>Inflammation Research<\/em> (2023): 1-10.<\/li>\n<li>Wu, Ting-Ting, et al. &#8220;Resistance training combined with \u03b2-hydroxy \u03b2-methylbutyrate for patients with critical illness: A four-arm, mixed-methods, feasibility randomised controlled trial.&#8221; <em>Intensive and Critical Care Nursing<\/em> 82 (2024): 103616.<\/li>\n<li>Wu, Ting-Ting, et al. &#8220;Effects of a multilevel intervention of resistance training with or without beta-hydroxy-beta-methylbutyrate in medical ICU patients during entire hospitalisation: a four-arm multicentre randomised controlled trial.&#8221; <em>Critical Care<\/em> 27.1 (2023): 493.<\/li>\n<li>Cai, Bin, et al. &#8220;Influence of body composition assessment with bioelectrical impedance vector analysis in cancer patients undergoing surgery.&#8221; <em>Frontiers in Oncology<\/em> 13 (2023).<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Akern\u00ae&#8216;s partnership with the Chinese company EnterNutr Guangzhou New Health Biotechnology Co., Ltd., a Guangzhou-based company founded in 2008 by Dr. Hanxi Li, started in 2019. Today EnterNutr is a company supported by governmental funds and well-established in the hospital setting in providing supplements and devices for parenteral nutrition therapy. In 2022 Akern\u00ae obtained NMPA [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11072,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-11084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsroom"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Akern consolidates relations with China - Akern<\/title>\n<meta name=\"description\" content=\"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akern consolidates relations with China - Akern\" \/>\n<meta property=\"og:description\" content=\"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/\" \/>\n<meta property=\"og:site_name\" content=\"Akern\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-15T10:00:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-16T11:49:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png\" \/>\n\t<meta property=\"og:image:width\" content=\"964\" \/>\n\t<meta property=\"og:image:height\" content=\"508\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"zaki\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"zaki\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/\",\"url\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/\",\"name\":\"Akern consolidates relations with China - Akern\",\"isPartOf\":{\"@id\":\"https:\/\/www.akern.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png\",\"datePublished\":\"2023-04-15T10:00:45+00:00\",\"dateModified\":\"2024-02-16T11:49:35+00:00\",\"author\":{\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082\"},\"description\":\"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage\",\"url\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png\",\"contentUrl\":\"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png\",\"width\":964,\"height\":508},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.akern.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akern consolidates relations with China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.akern.com\/en\/#website\",\"url\":\"https:\/\/www.akern.com\/en\/\",\"name\":\"Akern\",\"description\":\"Science in body composition\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.akern.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082\",\"name\":\"zaki\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.akern.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g\",\"caption\":\"zaki\"},\"sameAs\":[\"https:\/\/www.akern.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akern consolidates relations with China - Akern","description":"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/","og_locale":"en_US","og_type":"article","og_title":"Akern consolidates relations with China - Akern","og_description":"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.","og_url":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/","og_site_name":"Akern","article_published_time":"2023-04-15T10:00:45+00:00","article_modified_time":"2024-02-16T11:49:35+00:00","og_image":[{"width":964,"height":508,"url":"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png","type":"image\/png"}],"author":"zaki","twitter_card":"summary_large_image","twitter_misc":{"Written by":"zaki","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/","url":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/","name":"Akern consolidates relations with China - Akern","isPartOf":{"@id":"https:\/\/www.akern.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage"},"image":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage"},"thumbnailUrl":"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png","datePublished":"2023-04-15T10:00:45+00:00","dateModified":"2024-02-16T11:49:35+00:00","author":{"@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082"},"description":"Explore the strategic partnership between Akern\u00ae and EnterNutr, pioneers in parenteral nutrition therapy and medical technology. With the recent NMPA certification, Akern\u00ae expands its presence in major Chinese hospitals, promoting advanced research in critical care, oncology and geriatrics. Discover how our collaboration is defining the future of clinical care and support.","breadcrumb":{"@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#primaryimage","url":"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png","contentUrl":"https:\/\/www.akern.com\/wp-content\/uploads\/2024\/02\/akern-cina.png","width":964,"height":508},{"@type":"BreadcrumbList","@id":"https:\/\/www.akern.com\/en\/newsroom\/akern-consolidates-relations-with-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.akern.com\/en\/"},{"@type":"ListItem","position":2,"name":"Akern consolidates relations with China"}]},{"@type":"WebSite","@id":"https:\/\/www.akern.com\/en\/#website","url":"https:\/\/www.akern.com\/en\/","name":"Akern","description":"Science in body composition","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.akern.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/7a895617b6488a7518e22d839754c082","name":"zaki","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.akern.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/948c25419871836ed464a25639dfb8b147f61fe1543499599bc07cd9592c2def?s=96&d=mm&r=g","caption":"zaki"},"sameAs":["https:\/\/www.akern.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/11084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/comments?post=11084"}],"version-history":[{"count":3,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/11084\/revisions"}],"predecessor-version":[{"id":11088,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/posts\/11084\/revisions\/11088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/media\/11072"}],"wp:attachment":[{"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/media?parent=11084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/categories?post=11084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.akern.com\/en\/wp-json\/wp\/v2\/tags?post=11084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}